TrialJournal of acquired immune deficiency syndromes (1999)2019

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.

Willem Daniel Francois Venter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.